China Botanic Pharmaceutical (CBP) Reports Q3 EPS of $0.09

China Botanic Pharmaceutical (NYSE: CBP) reported Q3 EPS of $0.09, versus $0.07 reported last year. Revenue for the quarter came in at $15.08 million, versus $12.38 million reported last year.

For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Canterbury Park (CPHC) Misses Q2 EPS by 3c
• Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37